Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Astronomers may have spotted the 1st known 'superkilonova' double star explosion - 2Grasping the Basics of Business Land Regulation
- 3Nature carves colossal snowman in Siberia | Space photo of the day for Jan. 2, 2026
- 4Mountain Trekking on a Tight spending plan: Tracking down the Right Bicycle
- 5Many European nations want Israel to cancel 19 new settlement plans
- What's your #1 tone
- Genome study reveals milestone in history of cat domestication
- Interstellar comet 3I/ATLAS isn't an alien spacecraft, astronomers confirm. 'In the end, there were no surprises.'
- Parents speak out as 4-year-old fights button battery injury in intensive care unit
- Key Caper d: A Survey of \Procedure and Tomfoolery Released\ Tabletop game
- Trump says Venezuela will start 'turning over' oil to the U.S. Is that the reason he toppled Maduro — or is it something else?
- Relive NASA's historic Artemis 2 launch to the moon in these stunning photos
- UN warns civil liberties under threat due to war in Middle East
- The Best Business visionaries Under 30
